glutamine and Bile Duct Cancer

glutamine has been researched along with Bile Duct Cancer in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Kim, J; Lee, JM; Lee, JS; Lee, JY; Yang, SM1
Kang, MJ; Kim, MJ; Lee, SG; Noh, JY; Park, JM; Pyun, JC; Yoo, BC; Yun, TG1
Chenvidhya, D; Fujii, T; Honjo, S; Jedpiyawongse, A; Matharit, M; Miwa, M; Ohshima, K; Ohta, E; Sripa, B; Srivatanakul, P; Tanaka, H; Tanaka, M; Viwatthanasittiphong, C; You, G; Zeng, L1

Other Studies

3 other study(ies) available for glutamine and Bile Duct Cancer

ArticleYear
Regulation of glucose and glutamine metabolism to overcome cisplatin resistance in intrahepatic cholangiocarcinoma.
    BMB reports, 2023, Volume: 56, Issue:11

    Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Cisplatin; Glucose; Glutamine; Humans

2023
Simultaneous Analysis of Multiple Cancer Biomarkers Using MALDI-TOF Mass Spectrometry Based on a Parylene-Matrix Chip.
    Journal of the American Society for Mass Spectrometry, 2020, Apr-01, Volume: 31, Issue:4

    Topics: Bile Duct Neoplasms; Biomarkers, Tumor; Cholangiocarcinoma; Colorectal Neoplasms; Equipment Design; Glutamine; Humans; Limit of Detection; Lysophosphatidylcholines; Polymers; Pyridones; Reproducibility of Results; Solubility; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Xylenes

2020
Combined effects of polymorphisms of DNA-repair protein genes and metabolic enzyme genes on the risk of cholangiocarcinoma.
    Japanese journal of clinical oncology, 2013, Volume: 43, Issue:12

    Topics: Alanine; Arginine; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cysteine; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; Genotype; Glutamine; Glutathione Transferase; Histidine; Humans; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Risk Assessment; Risk Factors; Serine; Valine; X-ray Repair Cross Complementing Protein 1

2013